Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches

使用化学酶方法探索 Siglec-聚糖配体相互作用

基本信息

  • 批准号:
    10417251
  • 负责人:
  • 金额:
    $ 79.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-04 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Regulation of the immune system is substantially influenced by glycosylation. Cell-surface glycans tune ligand-receptor binding and set a threshold for initiating the downstream signaling for immune cell activation. Siglecs (sialic acid-binding immunoglobulin-type lectins) are a family of regulatory receptors involved in these processes. A Siglec can bind to both cis and trans sialylated glycan ligands that are expressed on the same or interacting cells, respectively. The binding of Siglecs with their ligands can either segregate Siglecs from activation receptors or move them closer. The ability of inhibitory Siglecs to modulate activation receptors is regulated by spatial proximity: recruiting Siglecs to the immune synapse in the proximity of activation receptors would trigger inhibitory signaling to suppress immune-system activation, whereas moving Siglecs away from activation receptors would enable optimal signaling through activation receptors. For the above reasons, recently, Siglecs have been described as glyco-immune checkpoints. Through their interaction with sialylated glycans aberrantly expressed on tumor cells, innate immune cell-associated Siglecs trigger signaling cascades to inhibit immune-system activation. Likewise, Siglecs upregulated on tumor cells interact with yet-to-be identified T-cell membrane glycoproteins to suppress T cell anti-tumor functions. On the positive side, however, inhibitory signaling through Siglecs curbs inflammation during cell death induced by viral infection. Despite these intriguing observations, the mechanisms underlying the above processes are just starting to be elucidated. The overarching goal of this project is to use a combination of chemoenzymatic, biochemical and genetic tools to explore Siglec-glycan ligand interactions and their therapeutic implication. In Aim 1, we will design Siglec-based chimeric switch receptors and convert inhibitory Siglecs into activation receptors. In Aim 2, we will use a cell-based glycan array platform to screen for high-affinity and specific ligands of Siglecs. Once identified, we will explore their utilities to suppress or harness the inhibitory Siglec signaling for therapeutic applications. Finally, we will use our chemoenzymatic tools to investigate how the Siglec-cis ligand interaction is involved in mediating the Siglec–trans ligand interaction and accordingly immune cell activation (Aim 3).
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peng Wu其他文献

Peng Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peng Wu', 18)}}的其他基金

Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10555320
  • 财政年份:
    2021
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10799053
  • 财政年份:
    2021
  • 资助金额:
    $ 79.59万
  • 项目类别:
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
使用化学酶方法探索 Siglec-聚糖配体相互作用
  • 批准号:
    10297728
  • 财政年份:
    2021
  • 资助金额:
    $ 79.59万
  • 项目类别:
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
使用化学酶方法探索 Siglec-聚糖配体相互作用
  • 批准号:
    10621946
  • 财政年份:
    2021
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemoenzymatic glycan editing for deciphering biological functions of glycans
化学酶聚糖编辑破译聚糖的生物学功能
  • 批准号:
    10329937
  • 财政年份:
    2021
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemical Tools for Studying Fucosylated Glycans
用于研究岩藻糖基化聚糖的化学工具
  • 批准号:
    9320789
  • 财政年份:
    2016
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemical Tools for Studying Fucosylated Glycans
用于研究岩藻糖基化聚糖的化学工具
  • 批准号:
    9105947
  • 财政年份:
    2016
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemoenzymatic methods for the detection of cell-surface glycans
检测细胞表面聚糖的化学酶法
  • 批准号:
    8964803
  • 财政年份:
    2015
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemical tools for studying fucosylated glycans
研究岩藻糖基化聚糖的化学工具
  • 批准号:
    8535787
  • 财政年份:
    2010
  • 资助金额:
    $ 79.59万
  • 项目类别:
Chemical tools for studying fucosylated glycans
研究岩藻糖基化聚糖的化学工具
  • 批准号:
    8326225
  • 财政年份:
    2010
  • 资助金额:
    $ 79.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了